Ischemic Preconditioning and Clinical Scenarios

Overview

Journal Curr Opin Neurol

Specialty Neurology

Date 2012 Dec 1

PMID 23197083

Citations 41

Authors

Srinivasan V Narayanan

Kunjan R Dave

Miguel A Perez-Pinzon

Affiliations

Soon will be listed here.

Abstract

Purpose Of Review: Ischemic preconditioning (IPC) is gaining attention as a novel neuroprotective therapy and could provide an improved mechanistic understanding of tolerance to cerebral ischemia. The purpose of this article is to review the recent work in the field of IPC and its applications to clinical scenarios.

Recent Findings: The cellular signaling pathways that are activated following IPC are now better understood and have enabled investigators to identify several IPC mimetics. Most of these studies were performed in rodents, and efficacy of these mimetics remains to be evaluated in human patients. Additionally, remote ischemic preconditioning (RIPC) may have higher translational value than IPC. Repeated cycles of temporary ischemia in a remote organ can activate protective pathways in the target organ, including the heart and brain. Clinical trials are underway to test the efficacy of RIPC in protecting brain against subarachnoid hemorrhage.

Summary: IPC, RIPC, and IPC mimetics have the potential to be therapeutic in various clinical scenarios. Further understanding of IPC-induced neuroprotection pathways and utilization of clinically relevant animal models are necessary to increase the translational potential of IPC in the near future.

Citing Articles

Differential Cytoprotective Effect of Resveratrol and Its Derivatives: Focus on Antioxidant and Autophagy-Inducing Effects.

Varga K, Paszternak A, Kovacs V, Guczogi A, Sikur N, Patakfalvi D Int J Mol Sci. 2024; 25(20).

PMID: 39457058 PMC: 11509103. DOI: 10.3390/ijms252011274.

Hypometabolism, Alzheimer's Disease, and Possible Therapeutic Targets: An Overview.

Raut S, Bhalerao A, Powers M, Gonzalez M, Mancuso S, Cucullo L Cells. 2023; 12(16).

PMID: 37626828 PMC: 10453773. DOI: 10.3390/cells12162019.

Madder () Alleviates Myocardial Ischemia-Reperfusion Injury by Protecting Endothelial Cells from Apoptosis and Inflammation.

Gao J, Wang Z, Ye Z Mediators Inflamm. 2023; 2023:5015039.

PMID: 36875688 PMC: 9981279. DOI: 10.1155/2023/5015039.

Resveratrol Preconditioning Downregulates PARP1 Protein to Alleviate PARP1-Mediated Cell Death Following Cerebral Ischemia.

Jackson C, Xu J, Escobar I, Saul I, Fagerli E, Dave K Transl Stroke Res. 2023; 15(1):165-178.

PMID: 36633794 PMC: 10336177. DOI: 10.1007/s12975-022-01119-z.

Neuroprotective effects of long noncoding RNAs involved in ischemic postconditioning after ischemic stroke.

Ma W, Li C, Zhang S, Zang C, Yang J, Wu Z Neural Regen Res. 2021; 17(6):1299-1309.

PMID: 34782575 PMC: 8643058. DOI: 10.4103/1673-5374.327346.

References

Morris K, Lin H, Thompson J, Perez-Pinzon M . Pathways for ischemic cytoprotection: role of sirtuins in caloric restriction, resveratrol, and ischemic preconditioning. J Cereb Blood Flow Metab. 2011; 31(4):1003-19. PMC: 3070983. DOI: 10.1038/jcbfm.2010.229. View

Ginsberg M . Current status of neuroprotection for cerebral ischemia: synoptic overview. Stroke. 2008; 40(3 Suppl):S111-4. PMC: 2697575. DOI: 10.1161/STROKEAHA.108.528877. View

Leesar M, Stoddard M, Dawn B, Jasti V, Masden R, Bolli R . Delayed preconditioning-mimetic action of nitroglycerin in patients undergoing coronary angioplasty. Circulation. 2001; 103(24):2935-41. DOI: 10.1161/01.cir.103.24.2935. View

Ghiardi G, Gidday J, Roth S . The purine nucleoside adenosine in retinal ischemia-reperfusion injury. Vision Res. 1999; 39(15):2519-35. DOI: 10.1016/s0042-6989(99)00038-3. View

Lange-Asschenfeldt C, Raval A, Dave K, Mochly-Rosen D, Sick T, Perez-Pinzon M . Epsilon protein kinase C mediated ischemic tolerance requires activation of the extracellular regulated kinase pathway in the organotypic hippocampal slice. J Cereb Blood Flow Metab. 2004; 24(6):636-45. DOI: 10.1097/01.WCB.0000121235.42748.BF. View

Hoole S, Heck P, Sharples L, Khan S, Duehmke R, Densem C . Cardiac Remote Ischemic Preconditioning in Coronary Stenting (CRISP Stent) Study: a prospective, randomized control trial. Circulation. 2009; 119(6):820-7. DOI: 10.1161/CIRCULATIONAHA.108.809723. View

Stroev S, Tyulkova E, Glushchenko T, Tugoi I, Samoilov M, Pelto-Huikko M . Thioredoxin-1 expression levels in rat hippocampal neurons in moderate hypobaric hypoxia. Neurosci Behav Physiol. 2008; 39(1):1-5. DOI: 10.1007/s11055-008-9091-5. View

Koch S, Sacco R, Perez-Pinzon M . Preconditioning the brain: moving on to the next frontier of neurotherapeutics. Stroke. 2012; 43(6):1455-7. PMC: 4086165. DOI: 10.1161/STROKEAHA.111.646919. View

Kato H, Araki T, Kogure K . Preserved neurotransmitter receptor binding following ischemia in preconditioned gerbil brain. Brain Res Bull. 1992; 29(3-4):395-400. DOI: 10.1016/0361-9230(92)90074-8. View

10.

Zhang H, Du G, Zhang J . Ischemic pre-conditioning preserves brain mitochondrial functions during the middle cerebral artery occlusion in rat. Neurol Res. 2003; 25(5):471-6. DOI: 10.1179/016164103101201878. View

11.

Dave K, DeFazio R, Raval A, Torraco A, Saul I, Barrientos A . Ischemic preconditioning targets the respiration of synaptic mitochondria via protein kinase C epsilon. J Neurosci. 2008; 28(16):4172-82. PMC: 2678917. DOI: 10.1523/JNEUROSCI.5471-07.2008. View

12.

Fisher M, Feuerstein G, Howells D, Hurn P, Kent T, Savitz S . Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke. 2009; 40(6):2244-50. PMC: 2888275. DOI: 10.1161/STROKEAHA.108.541128. View

13.

Correia S, Carvalho C, Cardoso S, Santos R, Santos M, Oliveira C . Mitochondrial preconditioning: a potential neuroprotective strategy. Front Aging Neurosci. 2010; 2. PMC: 2936931. DOI: 10.3389/fnagi.2010.00138. View

14.

Dirnagl U, Meisel A . Endogenous neuroprotection: mitochondria as gateways to cerebral preconditioning?. Neuropharmacology. 2008; 55(3):334-44. DOI: 10.1016/j.neuropharm.2008.02.017. View

15.

Murry C, Jennings R, Reimer K . Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986; 74(5):1124-36. DOI: 10.1161/01.cir.74.5.1124. View

16.

Kelkka T, Hultqvist M, Nandakumar K, Holmdahl R . Enhancement of antibody-induced arthritis via Toll-like receptor 2 stimulation is regulated by granulocyte reactive oxygen species. Am J Pathol. 2012; 181(1):141-50. DOI: 10.1016/j.ajpath.2012.03.031. View

17.

Leung P, Stevens S, Packard A, Lessov N, Yang T, Conrad V . Toll-like receptor 7 preconditioning induces robust neuroprotection against stroke by a novel type I interferon-mediated mechanism. Stroke. 2012; 43(5):1383-9. PMC: 3943206. DOI: 10.1161/STROKEAHA.111.641522. View

18.

Stroev S, Gluschenko T, Tjulkova E, Spyrou G, Rybnikova E, Samoilov M . Preconditioning enhances the expression of mitochondrial antioxidant thioredoxin-2 in the forebrain of rats exposed to severe hypobaric hypoxia. J Neurosci Res. 2004; 78(4):563-9. DOI: 10.1002/jnr.20282. View

19.

Schurr A, Reid K, Tseng M, West C, Rigor B . Adaptation of adult brain tissue to anoxia and hypoxia in vitro. Brain Res. 1986; 374(2):244-8. DOI: 10.1016/0006-8993(86)90418-x. View

20.

Plamondon H, DAvignon G, Khan S, Charron C . Cerebral ischemic preconditioning induces lasting effects on CA1 neuronal survival, prevents memory impairments but not ischemia-induced hyperactivity. Behav Brain Res. 2008; 189(1):145-51. DOI: 10.1016/j.bbr.2007.12.027. View